{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:39:25Z","timestamp":1790343565644,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070959"],"award-info":[{"award-number":["32070959"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515010732"],"award-info":[{"award-number":["2024A1515010732"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022A1515011795"],"award-info":[{"award-number":["2022A1515011795"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1105900"],"award-info":[{"award-number":["2022YFA1105900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neuropharm.2025.110504","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:53:18Z","timestamp":1746586398000},"page":"110504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rapamycin exerts neuroprotective effects by inhibiting FKBP12 instead of mTORC1 in the mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"275","author":[{"given":"Zeyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8912-3924","authenticated-orcid":false,"given":"Shiming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-7353","authenticated-orcid":false,"given":"Junyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-5939","authenticated-orcid":false,"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianchu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-9468","authenticated-orcid":false,"given":"Shanshan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-2509","authenticated-orcid":false,"given":"Qiaoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuropharm.2025.110504_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neuroscience.2009.04.031","article-title":"A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL\/6J mouse","volume":"161","author":"Baquet","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110504_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ebiom.2019.03.025","article-title":"Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease","volume":"42","author":"Barriocanal-Casado","year":"2019","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110504_bib3","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","article-title":"mTOR substrate phosphorylation in growth control","volume":"185","author":"Battaglioni","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110504_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110504_bib5","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110504_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110504_bib7","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4103\/1673-5374.284980","article-title":"Mounting evidence of FKBP12 implication in neurodegeneration","volume":"15","author":"Caminati","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2025.110504_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105638","article-title":"An immunomodulatory role of Fc receptor \u03b3 chain independent of Fc\u03b3R ligation by IgG in acute neuroinflammation triggered by MPTP intoxication","volume":"171","author":"Chen","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2025.110504_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105298","article-title":"GDNF signaling in subjects with minimal motor deficits and Parkinson's disease","volume":"153","author":"Chu","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"163","key":"10.1016\/j.neuropharm.2025.110504_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004676","article-title":"\u03b1-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons","volume":"4","author":"Decressac","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110504_bib11","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"37","key":"10.1016\/j.neuropharm.2025.110504_bib12","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"issue":"30","key":"10.1016\/j.neuropharm.2025.110504_bib13","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M110.182303","article-title":"Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation","volume":"286","author":"Deleersnijder","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.neuropharm.2025.110504_bib14","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1523\/JNEUROSCI.0900-16.2016","article-title":"Reversal of pathologic lipid accumulation in NPC1-deficient neurons by drug-promoted release of LAMP1-coated lamellar inclusions","volume":"36","author":"Demais","year":"2016","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110504_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cns.13062","article-title":"Rapamycin and FK506 derivative TH2849 could ameliorate neurodegenerative diseases through autophagy with low immunosuppressive effect","volume":"25","author":"Ding","year":"2019","journal-title":"CNS Neurosci. Ther."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110504_bib16","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1096\/fj.11-181958","article-title":"Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models","volume":"25","author":"Domanskyi","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110504_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-5-26","article-title":"The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"5","author":"Fox","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00429-011-0349-2","article-title":"A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse","volume":"217","author":"Fu","year":"2012","journal-title":"Brain Struct. Funct."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110504_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1471-4159.2008.05342.x","article-title":"FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T","volume":"106","author":"Gerard","year":"2008","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110504_bib20","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1523\/JNEUROSCI.5983-09.2010","article-title":"Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology","volume":"30","author":"Gerard","year":"2010","journal-title":"J. Neurosci."},{"issue":"368","key":"10.1016\/j.neuropharm.2025.110504_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2210","article-title":"Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease","volume":"8","author":"Ghosh","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110504_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.761773","article-title":"TFE3-Mediated autophagy is involved in dopaminergic neurodegeneration in Parkinson's disease","volume":"9","author":"He","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2025.110504_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainres.2017.12.012","article-title":"FKBP12-immunopositive inclusions in patients with \u03b1-synucleinopathies","volume":"1680","author":"Honjo","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110504_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106105","article-title":"Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease","volume":"180","author":"Huang","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110504_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","article-title":"Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion","volume":"21","author":"Huang","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80555-3","article-title":"Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12","volume":"96","author":"Huse","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110504_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110504_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105805","article-title":"The promise of the TGF-\u03b2 superfamily as a therapeutic target for Parkinson's disease","volume":"171","author":"Karampetsou","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acn3.51505","article-title":"Sirolimus for epileptic seizures associated with focal cortical dysplasia type II","volume":"9","author":"Kato","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"724","key":"10.1016\/j.neuropharm.2025.110504_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add0499","article-title":"Enhanced mTORC1 signaling and protein synthesis in pathologic \u03b1-synuclein cellular and animal models of Parkinson's disease","volume":"15","author":"Khan","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/mt.2011.213","article-title":"AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth","volume":"20","author":"Kim","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110504_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75398","article-title":"Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2","volume":"11","author":"Kosillo","year":"2022","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110504_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110504_bib36","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1212\/WNL.0000000000003400","article-title":"Long-term treatment of epilepsy with everolimus in tuberous sclerosis","volume":"87","author":"Krueger","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110504_bib37","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1096\/fj.201600495R","article-title":"mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type","volume":"30","author":"Li","year":"2016","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110504_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnmol.2020.00081","article-title":"GSK-3\u03b2 contributes to parkinsonian dopaminergic neuron death: evidence from conditional knockout mice and tideglusib","volume":"13","author":"Li","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110504_bib40","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4103\/1673-5374.371381","article-title":"Rapamycin reverses ferroptosis by increasing autophagy in MPTP\/MPP(+)-induced models of Parkinson's disease","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2025.110504_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2015.08.006","article-title":"Transforming growth factor-\u03b21 acts via T\u03b2R-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss","volume":"51","author":"Liu","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib43","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110504_bib44","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1038\/s41467-023-40734-8","article-title":"Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis","volume":"14","author":"Mandrioli","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110504_bib45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/CS20171457","article-title":"Rapamycin activates TGF receptor independently of its ligand: implications for endothelial dysfunction","volume":"132","author":"Miyakawa","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.neuropharm.2025.110504_bib46","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.2147\/JIR.S338815","article-title":"Modulation of sirt1-mTORC1 pathway in microglia attenuates retinal ganglion cell loss after optic nerve injury","volume":"14","author":"Mou","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110504_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110504_bib48","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mds.28923","article-title":"mTOR inhibition with sirolimus in multiple system atrophy: a randomized, double-blind, placebo-controlled futility trial and 1-year biomarker longitudinal analysis","volume":"37","author":"Palma","year":"2022","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1523\/JNEUROSCI.0590-10.2011","article-title":"Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling","volume":"31","author":"Rieker","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110504_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011056","article-title":"Natural product ligands of FKBP12: immunosuppressive antifungal agents FK506, rapamycin, and beyond","volume":"19","author":"Rivera","year":"2023","journal-title":"PLoS Pathog."},{"issue":"49","key":"10.1016\/j.neuropharm.2025.110504_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1014633107","article-title":"Rapamycin induces autophagic flux in neurons","volume":"107","author":"Rubinsztein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.neuropharm.2025.110504_bib52","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.celrep.2015.12.055","article-title":"The rag-ragulator complex regulates lysosome function and phagocytic flux in microglia","volume":"14","author":"Shen","year":"2016","journal-title":"Cell Rep."},{"issue":"27","key":"10.1016\/j.neuropharm.2025.110504_bib54","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR activation upregulates Trem2 and enhances \u03b2-amyloid plaque clearance in the 5XFAD Alzheimer's disease model","volume":"42","author":"Shi","year":"2022","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib55","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","article-title":"Neuroprotective effects of temsirolimus in animal models of Parkinson's disease","volume":"55","author":"Siracusa","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"6387","key":"10.1016\/j.neuropharm.2025.110504_bib56","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/358584a0","article-title":"High brain densities of the immunophilin FKBP colocalized with calcineurin","volume":"358","author":"Steiner","year":"1992","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.neuropharm.2025.110504_bib57","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","article-title":"Deficiency in neuronal TGF-\u03b2 signaling leads to nigrostriatal degeneration and activation of TGF-\u03b2 signaling protects against MPTP neurotoxicity in mice","volume":"37","author":"Tesseur","year":"2017","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/15548627.2015.1134080","article-title":"Control of lysosomal biogenesis and Notch-dependent tissue patterning by components of the TFEB-V-ATPase axis in Drosophila melanogaster","volume":"12","author":"Tognon","year":"2016","journal-title":"Autophagy"},{"issue":"5172","key":"10.1016\/j.neuropharm.2025.110504_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.7518616","article-title":"Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12","volume":"265","author":"Wang","year":"1994","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)80116-6","article-title":"The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors","volume":"86","author":"Wang","year":"1996","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110504_bib61","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.227777","article-title":"FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation","volume":"132","author":"Wang","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2025.110504_bib62","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fphar.2018.00877","article-title":"Rapamycin upregulates connective tissue growth factor expression in hepatic progenitor cells through TGF-\u03b2-smad2 dependent signaling","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110504_bib63","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1523\/JNEUROSCI.1419-21.2022","article-title":"CREB inactivation by HDAC1\/PP1\u03b3 contributes to dopaminergic neurodegeneration in Parkinson's disease","volume":"42","author":"Xu","year":"2022","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.neuropharm.2025.110504_bib64","doi-asserted-by":"crossref","first-page":"13149","DOI":"10.1074\/jbc.275.17.13149","article-title":"FKBP12 is a negative regulator of transforming growth factor-beta receptor internalization","volume":"275","author":"Yao","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110504_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12974-023-02886-8","article-title":"Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition","volume":"20","author":"Yao","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110504_bib66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-019-1644-8","article-title":"Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation","volume":"17","author":"Ye","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110504_bib67","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/epi.14526","article-title":"The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex","volume":"59","author":"Zhang","year":"2018","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110504_bib68","article-title":"Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"40","key":"10.1016\/j.neuropharm.2025.110504_bib69","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1523\/JNEUROSCI.2754-19.2020","article-title":"Microglial mTOR is neuronal protective and antiepileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"40","author":"Zhao","year":"2020","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110504_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR signaling and autophagy in the treatment of Parkinson's disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:14:37Z","timestamp":1778300077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"alternative-id":["S0028390825002102"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110504","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin exerts neuroprotective effects by inhibiting FKBP12 instead of mTORC1 in the mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110504"}}